Who owns NEUROPACE INC?
- Ticker: NPCE
- CUSIP Number: 641288105
Tip: Access positions for across all investors
Analyze quarterly positions in Neuropace with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neuropace stock
Who bought or sold NEUROPACE INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 4.0M | $53M | 0% | Mar 2024 |
|
| Morgan Stanley | 2.5M | $33M | 4% | Mar 2024 |
|
| Soleus Capital Management | 2.4M | $32M | 0% | Mar 2024 |
|
| Nantahala Capital Management | 778k | $10M | -34% | Mar 2024 |
|
| Kent Lake Capital | 644k | $8.5M | -4% | Mar 2024 |
|
| Millennium Management | 606k | $8.0M | 251% | Mar 2024 |
|
| Vanguard Group | 489k | $6.4M | 18% | Mar 2024 |
|
| FMR | 303k | $4.0M | -57% | Mar 2024 |
|
| Susquehanna International | 218k | $2.9M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 140k | $1.8M | 100% | Mar 2024 |
|
| Geode Capital Management | 117k | $1.5M | 6% | Mar 2024 |
|
| Citigroup | 76k | $999k | 116% | Mar 2024 |
|
| Eudaimonia Asset Management | 76k | $998k | -47% | Mar 2024 |
|
| BlackRock | 74k | $979k | 24% | Mar 2024 |
|
| Jane Street | 72k | $951k | 96% | Mar 2024 |
|
| Marshall Wace | 58k | $770k | 312% | Mar 2024 |
|
| Cubist Systematic Strategies | 51k | $670k | 344% | Mar 2024 |
|
| Acadian Asset Management | 47k | $621k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 45k | $597k | 1785% | Mar 2024 |
|
| Man Group | 38k | $501k | 97% | Mar 2024 |
|
| Bridgeway Capital Management | 33k | $438k | -45% | Mar 2024 |
|
| Jpmorgan Chase & Co | 32k | $424k | 183% | Mar 2024 |
|
| Hrt Financial | 32k | $421k | 100% | Mar 2024 |
|
| Northern Trust | 30k | $391k | 33% | Mar 2024 |
|
| Marathon Trading Investment Management | 28k | $370k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 27k | $356k | -1% | Mar 2024 |
|
| Petrus Trust Company | 24k | $316k | 100% | Mar 2024 |
|
| Laurion Capital Management | 21k | $273k | 0% | Mar 2024 |
|
| Citadel Advisors | 21k | $273k | -14% | Mar 2024 |
|
| Walleye Trading Advisors | 20k | $260k | 38% | Mar 2024 |
|
| ExodusPoint Capital Management | 19k | $256k | 100% | Mar 2024 |
|
| Options Solutions | 19k | $244k | 100% | Mar 2024 |
|
| XTX Topco | 15k | $203k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 15k | $198k | 100% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 14k | $190k | 100% | Mar 2024 |
|
| Barclays | 14k | $177k | -1% | Mar 2024 |
|
| Bank of America Corporation | 14k | $181k | -57% | Mar 2024 |
|
| Squarepoint Ops | 13k | $176k | 100% | Mar 2024 |
|
| Hillsdale Investment Management | 12k | $155k | 100% | Mar 2024 |
|
| Leucadia National Corporation | 11k | $144k | 100% | Mar 2024 |
|
| Y-Intercept | 11k | $139k | 100% | Mar 2024 |
|
| Point72 Asia | 10k | $137k | 3939% | Mar 2024 |
|
| Financial Advocates Investment Management | 10k | $132k | 0% | Mar 2024 |
|
| Caption Management | 10k | $132k | 100% | Mar 2024 |
|
| Lazard Asset Management | 3.9k | $40k | 100% | Dec 2023 |
|
| Tower Research Capital | 3.8k | $50k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 2.1k | $28k | 2470% | Mar 2024 |
|
| UBS Group | 1.7k | $22k | 100% | Mar 2024 |
|
| CWM | 166.00 | $2.0k | 100% | Mar 2024 |
|
| Federated Investors | 116.00 | $1.2k | -73% | Dec 2023 |
|
Who sold out of Neuropace?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| 683 Capital Management | Dec 2023 | 25k | $257k |
| Townsquare Capital | Dec 2023 | 16k | $164k |
| Virtu Financial | Dec 2023 | 11k | $111k |
| Advisor Group Holdings | Dec 2023 | 233.00 | $2.4k |
| Royal Bank of Canada | Dec 2023 | 118.00 | $1.0k |